METTL8 orchestrates TFH cell differentiation through m³C-mediated TCF1 regulation in infection and cancer models
T follicular helper (T FH ) cells are critical for humoral immunity against infections and correlate with immunotherapy efficacy, whereas immune checkpoint inhibitor therapy can drive their aberrant expansion, underscoring the need to understand the regulators controlling T FH cell fate. However, the epitranscriptomic regulation of their differentiation remains poorly understood. Here, we identify the 3-methylcytosine (m³C) methyltransferase METTL8 as a key regulator of T FH cell differentiation in both viral infection and cancer. METTL8 was preferentially expressed in CXCL13 hi T FH cells, and its deficiency impaired T FH differentiation and germinal center responses in the lymphocytic choriomeningitis virus infection model and following anti–PD-1 immunotherapy in tumor models. Mechanistically, METTL8 exerted dual functions: it bound and stabilized Tcf7 mRNA through m³C modification, and it interacted with TCF1 protein to regulate chromatin accessibility and 3D genome organization at key T FH -associated loci, including Cxcr5 and Il6ra . Notably, ginkgolic acid treatment suppressed T FH responses without compromising the antitumor efficacy of anti–PD-1 therapy, an effect associated with METTL8. Collectively, our findings identify METTL8 as an epitranscriptomic regulator linked to RNA modification, TCF1-associated transcriptional control, and chromatin architecture during T FH differentiation and suggest that modulation of this pathway may provide a strategy to tune T FH -driven immune responses.
Authors
- Tengfei Hu (ORCID: https://orcid.org/0000-0001-9033-5493)
- Rentao Yu (ORCID: https://orcid.org/0000-0003-4952-9274)
- Lilin Ye (ORCID: https://orcid.org/0000-0003-0778-3311)
- Qunfa Cao
- Handong Ma (ORCID: https://orcid.org/0000-0002-3945-2990)
- Ying Dai (ORCID: https://orcid.org/0000-0002-7251-2617)
- Bofeng Li (ORCID: https://orcid.org/0000-0002-9110-8804)
- Han Xu (ORCID: https://orcid.org/0000-0003-1975-1771)
- Dan Cui (ORCID: https://orcid.org/0000-0003-3710-1131)
- Qizhao Huang (ORCID: https://orcid.org/0000-0002-5073-311X)
- 嘉欣 马
- Jiabao Wang (ORCID: https://orcid.org/0009-0003-7030-0607)
- Xuewei Qi (ORCID: https://orcid.org/0009-0004-1339-5635)
- Fengyin Li
- Jiaxi Song
- Xiaoyuan Song
- Jing Yang
- Qing Liu
- Jia Li
- Xiaona Zhang
- Hua Wang
- Haoyu Yu
Institutions
- University of Science and Technology of China (CN)
- Chinese Academy of Sciences (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Guangzhou Laboratory (CN)
- Changping Laboratory (CN)
- Chongqing Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1172/jci199747
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00